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Abstract 
A new -pyrone, 6R-[5R,6S-diacetyloxy-1Z,3E-heptadienyl]-5,6-dihydro-2H-
pyran-2one (1), along with six known compounds including an α-pyrone, flavones 
and terpenes was isolated from the aerial parts of Neohyptis paniculata.  The structure 
of 1 was established unambiguously by MS and a series of 1D and 2D-NMR 
spectroscopic analyses. The antibacterial activity of the compounds (1-7) was 
investigated against five strains of multi-drug resistant (MDR) and methicillin-
resistant Staphylococcus aureus and minimum inhibitory concentrations (MICs) of 
these compounds were found to be in the range of 64-256 g/mL. 
Keywords 
Neohyptis paniculata, Lamiaceae, -pyrone, 6R-[5R,6S-diacetyloxy-1Z,3E-
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1. Introduction 
 
 Neohyptis paniculata (Bak.) J. K. (Lamiaceae), a slender and erect perennial herb 
attaining a height of 1-3 ft., is a monotypic species that is characterized by a small and 
white corolla with purple dots.  The plant grows well in savanna swamps of some 
African countries including Ghana, Guinea, Angola, Cameroon, Angola and Sierra-
Leone [1]. This species has not been previously investigated for phytochemistry and 
bioactivity. 
 Infections caused by multidrug-resistant (MDR) and methicillin-resistant strains 
of Staphylococcus aureus (MRSA) are still problematic in the clinical environment 
and the need for new antibacterials is becoming increasingly urgent. As part of an on-
going effort to characterize new compounds from species of Lamiaceae [2,3] with 
antibacterial activity against multidrug-resistant (MDR) strains of Staphylococcus 
aureus, we here report the isolation of a new compound (1) together with six known 
compounds including an α-pyrone, flavones and terpenes from the aerial parts of N. 
paniculata and the antibacterial activities of compounds 1-7 against five bacterial 
strains of MDR and methicillin-resistant Staphylococcus aureus. 
2. Materials and Methods  
2.1  General.  
Optical rotations were measured on a Perkin Elmer Polarimeter 341. IR spectra 
were recorded as a dry film on a Perkin Elmer Spectrum 1000 FT-IR spectrometer. 
UV spectra were obtained on a Unicam UV 4-100 UV/vi spectrophotometer in 
MeOH. HREIMS were recorded on a Micromass Q-TOF Global Tandem Mass 
Spectrometer. NMR spectra (both 1D and 2D) were obtained on a Bruker AVANCE 
500 spectrometer (500 MHz for 1H and 125 MHz for 13C), using the residual solvent 
peaks as internal standard. Vacuum-liquid chromatography (VLC) was carried out 
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using Merck Si gel 60 H. Gel filtration was performed using Sephadex LH-20 
(Sigma). TLC and PTLC were conducted on normal-phase Merck Si gel 60 PF254 and 
reverse-phase Merck Si gel RP-18 PF254 plates (20 cm X 20 cm). Spots on TLC and 
PTLC plates were visualised under UV light (254 and 366 nm) and spraying with 1% 
vanillin-H2SO4 followed by heating at 110˚C for 5-10 min.  
2.2. Plant material 
The aerial parts of N. paniculata were collected from Ghana in 2006. A 
herbarium specimen of this collection is maintained at the UCL School of Pharmacy, 
University of London, UK.  
2.3. Extraction and isolation 
250 g of dried, ground plant material was sequentially extracted with hexane, 
CHCl3 and methanol in a Soxhlet apparatus. This sequential extraction with solvents 
of increasing polarity allowed preliminary separation of the components based on the 
polarity of the metabolites. As both hexane and chloroform extracts showed 
antibacterial activity, these two extracts were analysed further for the isolation and 
purification of compounds. 
The hexane extract (900 mg) was subjected to gel filtration over Sephadex 
LH20 (27 g) using a mobile phase of hexane, CHCl3 and MeOH in a ratio of 2:5:1 to 
obtain a total of 8 fractions (50 mL each fraction). Solid phase extraction (SPE) (Si 
60G; mobile phase 100% hexane to 100% EtOAc) on fraction 2 (200 mg) was carried 
out using hexane and EtOAc in a mixture of increasing polarity collecting 50 mL of 
each eluent. Preparative TLC (Si gel 60 PF254; 100% hexane) on the SPE sub-fraction 
eluted with 100% hexane afforded 2 (2.2 mg) and 3 (3.1 mg) while compounds 1 (2.5 
mg) and 4 (10.6 mg) were isolated from the SPE sub-fraction eluted with 50% EtOAc 
in hexane followed by preparative-TLC (Merck Si gel RP-18 PF254; MeOH: H2O: 
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AcOH= 59:40:1). Further, preparative TLC (Si gel 60 PF254; 15% EtOAc in toluene 
plus 3-4 drops of AcOH) on the SPE sub-fraction eluted with 10-20% EtOAc hexane 
led to the isolation of 5 (4.1 mg) and 7 (6.3 mg).  
The CHCl3 extract (5.5 g) was fractionated by VLC over Si gel 60H using 
hexane-EtOAc and EtOAc-MeOH mixtures of increasing polarity. The eluates were 
combined together on the basis of TLC analysis. VLC fractions eluted with 20-25% 
EtOAc in petroleum ether were further subjected to preparative-TLC to yield 5 (14.5 
mg) and 6 (16.6 mg). Gel filtration over Sephadex LH20 (hexane: CHCl3 : MeOH = 
2:5:1) on the VLC fractions eluting with 40-50% EtOAc in hexane gave 15.4 mg of 7. 
2.4.  6R-[5R,6S-diacetyloxy-1Z,3E-heptadienyl]-5,6-dihydro-2H-pyran-2one (1)  
White gum.  20D 30.1 (CHCl3; c 4.55). UV 
MeOH
max nm (log): 229 (4.26). IR 
(solution in CHCl3)  cm
-1: 1736, 1360, 1225, 1070, 1025, 955, 800; 1H NMR, 13C 
NMR and HMBC, see Table 2.  HRMS m/z [M+Na] peak at m/z 331.1157 (Calcd. 
331.1163). 
2.5. Bacterial strains 
A standard S. aureus strain ATCC 25923 and a clinical isolate (XU212), 
which possesses the TetK efflux pump and is also an MRSA strain, were obtained 
from E. Udo [4]. Strain RN4220 which has the MsrA macrolide efflux pump was 
provided by J. Cove [5]. EMRSA-15 [6] was obtained from Dr Paul Stapleton, UCL. 
Strain SA1199B which over-expresses the NorA MDR efflux pump was the gift of 
Professor Glenn Kaatz [7]. Norfloxacin was obtained from the Sigma Chemical Co.  
2.6.  Antibacterial assay 
Overnight cultures of each strain were made up in 0.9% saline to an inoculum 
density of 5 x 105 cfu/mL by comparison with a MacFarland standard. Tetracycline 
and oxacillin were dissolved directly in MHB, whereas norfloxacin and erythromycin 
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were dissolved in DMSO and then diluted in MHB to give a starting concentration of 
512 µg/mL. Using Nunc 96-well microtitre plates, 125 µL of MHB were dispensed 
into wells 1-11. 125µL of the test compound or the appropriate antibiotic were 
dispensed into well 1 and serially diluted across the plate leaving well 11 empty for 
the growth control. The final volume was dispensed into well 12, which being free of 
MHB or inoculum served as the sterile control. Finally, the bacterial inoculum (125 
µL) was added to wells 1-11 and the plate was incubated at 37ºC for 18 hours. A 
DMSO control (3.125%) was also included. All MICs were determined in duplicate. 
The MIC was determined as the lowest concentration at which no growth was 
observed. A methanolic solution (5 mg/mL) of 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazolium bromide (MTT; Lancaster) was used to detect bacterial growth 
by a colour change from yellow to blue [8]. 
3. Results and discussion 
The HREIMS of 1 showed an [M+Na] peak at m/z 331.1157 (calc. 331.1163) and 
thereby, established its molecular formula as C16H20O6. The 
13C and DEPT135 NMR 
experiments revealed the presence of 16 carbons; three methyls (15.2, 21.3 and 21.4), 
one methylene (29.9), three carbonyls (164.0, 170.3 and 170.6) and nine methines, 
three of which were oxygenated. The 1H NMR spectrum (500 MHz, CDCl3, Table 1) 
of 1 showed two acetoxy methyl groups which resonated at 2.06 (3H, s) and 2.09 (3H, 
s) and a further 3H signal at 1.22 (3H, d, J= 6.5 Hz) which was attributable to a 
terminal secondary methyl group. The spectrum also exhibited two olefinic protons of 
a  dihydropyrone skeleton [9] at 6.09 (dq, J = 10.0, 1.0 Hz) and 6.92 (ddd, J = 10.0, 
5.5, 3.0 Hz), two cis  olefinic protons (5.64, dd, J = 10.5, 9.0 Hz; 6.18, dd, J = 11.5, 
10.5 Hz) and two trans olefinic protons (6.52, dd, J = 15.0, 11.5 Hz; 5.77, dd, J = 
15.0, 7.0 Hz), one methylene (2.44, m) and three oxy-methines (5.08, 5.37 and 5.45).  
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The unambiguous assignment of all carbons and protons of 1 was achieved by a series 
of 2D experiments including HMQC, HMBC, COSY and NOESY. In the HMBC 
experiment, the proton at 6.92 (H-4) showed 3J connectivity to a carbonyl at 164.0 (C-
2), and to an oxygenated methine carbon at 74.0 (C-6; H 5.37 from HMQC). In the 
COSY experiment, H-4 revealed an expected interaction with H-3 (H 6.09; C 121.9) 
and H2-5 (2.44; C 29.9 from HMQC). These chemical shifts and their correlations 
supported the presence of 5,6-dihydro-2H-pyran-2-one as a part of the molecule.  The 
olefinic proton at 5.64 (H-1'; C 128.8 from HMQC) coupled to H-6 and H-2' (H 
6.18; C 131.4) in the COSY experiment and showed 
3J HMBC connectivity to a 
methylene carbon at 29.9 (C-5) and to an olefinic carbon at 128.4 (C-3'; H 6.52). The 
latter proton (H-3') coupled to H-2' and H-4' (H 5.77; C 130.6) in the COSY 
experiment and exhibited a 3J HMBC correlation to C-1' and to an oxygenated 
methine 74.8 (C-5'). The remaining oxy-methine proton at 5.08 (H-6') revealed a 
COSY interaction with H-5' and to a methyl doublet (J = 6.5 Hz) at 1.22 (H3-7'; 
C15.2 from HMQC). The remaining methyls at 2.06 and 2.09 ppm showed 
2J HMBC 
connectivity to their respective acetyl carbonyl carbons at 170.3 and 170.6. The 3J 
HMBC correlation by H-5' and H-6' to the carbonyls at 170.6 and 170.3 confirmed 
their connectivity via C-5' and C-6', respectively. Accordingly, compound 1 was 
therefore identified as 6-[5,6-diacetyloxy-1Z,3E-heptadienyl]-5,6-dihydro-2H-
pyran-2one (1, Fig 1; named neohyptolide) which is a new compound. Because of 
paucity of the compound, it was not possible to carry out further study to confirm the 
absolute stereochemistry of the compound. However, R-configuration was proposed at 
C-5 by comparing its 1H NMR data to other structurally related hyptolides [9, 10]. 
Again, in view of the similarity of the coupling constants of the side chain protons at 
C-5’ and C-6’ of 1 to hyptolides reported from Hyptis oblongifolia [9] and 
 9 
pectinolides from Hyptis pectinata [11], the configurations of these chiral centers of 1 
were assumed to be the same as in those compounds, i.e., R-configuration at C-5’ and 
S-configuration at C-6’. So taking these configurations into account, compound 1 was 
considered to be 6R-[5R,6S-diacetyloxy-1Z,3E-heptadienyl]-5,6-dihydro-2H-pyran-
2one. 
By direct comparison of spectral data to those published in the literature, 
compounds 2-7 were identified as α-himachalene (2) [12], 4-deacetoxy-10-epi-
olguine (3) [9], isoneocembrene-A (4) [13], -caryophyllene oxide (5) [14], 3,5-
dihydroxy-7,4’-dimethoxyflavone (6) [15], 5-hydroxy-3,7,4’-trimethoxyflavone (7) 
[15].  
All compounds (1-7) were assessed for anti-staphylococcal activity in a 
minimum inhibitory concentration (MIC) assay but displayed only weak to moderate 
activity (Table 2). Among the compounds, the comparatively better anti-
staphylococcal activity was exhibited by compound 1.  α–Pyrones with structural 
similarity to 1 have been reported to exhibit antibacterial properties including those 
against the clinical isolates of Staphylococcal aureus [16]. The cytotoxic potential of 
pectinolides was also reported with a number of cultured cell lines [16]. It is 
suggested that the presence of an alpha-beta unsaturated ketone, which is part of the 
lactone moiety may make this compound a substrate for biological nucleophiles and it 
is likely that this compound is also cytotoxic to mammalian cells as is seen in the case 
of the pectinolides [16]. 
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Table 1 
1H NMR (500 MHz), 13C NMR (125 MHz) and HMBC data of 1 in CDCl3 
 
 
Position 1H 13C HMBC 
2J 3J 
2 
3 
4 
5 
6 
1' 
2' 
3' 
4' 
5' 
6' 
7' 
CH3CO-5' 
CH3CO-6' 
CH3CO-5' 
CH3CO-6' 
- 
6.09, dq, J = 10.0, 1.0 Hz  
6.92, ddd, J = 10.0, 5.5, 3.0 Hz 
2.44, m 
5.37, ddt, J = 10.0, 5.0, 1.0 Hz  
5.64, dd, J = 10.5, 9.0 Hz 
6.18, dd, J = 11.5, 10.5 Hz 
6.52, dd, J = 15.0, 11.5 Hz 
5.77, dd, J = 15.0, 7.0 Hz  
5.45, ddd, , J= 7.0, 3.5, 1.0 Hz 
5.08, dq, J = 6.5, 3.5 Hz 
1.22, d, J = 6.5 Hz 
 2.09, s 
2.06, s 
- 
- 
164.0 
121.9 
144.8 
29.9 
74.0 
128.8 
131.4 
128.4 
130.6 
74.8 
70.7 
15.2 
21.3 
21.4 
170.6 
170.3 
- 
C-2, C-4 
C-3 
C-4 
- 
C-2' 
C-1', C-3' 
C-2', C-4' 
C-3', -5' 
C-6' 
C-5' 
C-6' 
CO-5' 
CO-6' 
- 
- 
- 
C-5 
C-2, C-6 
C-3, C-1' 
C-4, C-2' 
C-5, C-3' 
C-6, C-4' 
C-1', C-5' 
C-4', -6' 
C-3', -7' 
C-4' 
C-5' 
- 
- 
- 
- 
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Table 2 
Minimum Inhibitory Concentrations (g/mL) of compounds 1-7 against clinical 
isolates of multi-drug resistant (MDR) and methicillin-resistant strains of 
Staphylococcus aureus. 
 
Compounds SA1199B RN4220 EMRSA-15 XU-212 ATCC25923 
1 
2 
3 
4 
5 
6 
7 
Norfloxacin 
64 
64 
64 
64 
256 
256 
256 
32 
64 
64 
128 
128 
256 
128 
256 
2 
64 
128 
64 
128 
256 
128 
256 
1  
64 
64 
128 
64 
128 
128 
128 
16  
128 
128 
128 
128 
128 
128 
256 
1  
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Fig 1. Structures of compound 1-7 
 
